Skip to main content

01.05.2019 | Immunotherapy and Immunomodulators (B Vickery, Section Editor) | Ausgabe 5/2019

Current Allergy and Asthma Reports 5/2019

Microbial Adjuncts for Food Allergen Immunotherapy

Current Allergy and Asthma Reports > Ausgabe 5/2019
Hsi-en Ho, Supinda Bunyavanich
Wichtige Hinweise
This article is part of the Topical Collection on Immunotherapy and Immunomodulators

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.


Purpose of Review

Food allergen immunotherapy may benefit from adjunct therapies to enhance safety and efficacy. We review preclinical studies investigating the effects of probiotics and other microbial-based interventions on oral tolerance, describe the human clinical trial evidence thus far for microbial adjuncts, and discuss steps for translating research findings in this area to clinical therapy.

Recent Findings

Murine studies support that microbial-based interventions confer protection against sensitization and may augment treatment efficacy for food allergy. Microbial adjunct therapies can promote regulatory T cells and modulate Th1 vs. Th2 responses. There is a wide array of novel modalities utilizing microbial components. Ongoing efforts are focused on translating preclinical data into potential treatments.


Probiotics, prebiotics, and microbial components have all been examined as microbial adjunct therapies in murine models of food allergy. The effects of probiotics appear to be strain-specific. Prebiotics and bacterial components are innovative modalities to modulate oral tolerance. Better characterization of dysbiosis in human cohorts with food allergy, deeper mechanistic understanding of microbial adjunct therapies, safety evaluation, and careful clinical trial design will be crucial for the development of microbial adjuncts for food allergen immunotherapy. Microbial adjunct therapies have the potential to enhance the efficacy, safety, and durability of food allergen immunotherapy.

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

e.Med Interdisziplinär

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf

Über diesen Artikel

Weitere Artikel der Ausgabe 5/2019

Current Allergy and Asthma Reports 5/2019 Zur Ausgabe

Anaphylaxis and Drug Allergy (DA Khan and M Castells, Section Editors)

Chlorhexidine Allergy: On the Rise and Often Overlooked

Basic and Applied Science (I Lewkowich, Section Editor)

Th9 Cells in Allergic Disease

Rhinosinusitis (J Mullol, Section Editor)

Osteitis in Chronic Rhinosinusitis

Anaphylaxis and Drug Allergy (DA Khan and M Castells, Section Editors)

Evaluating Penicillin Allergies Without Skin Testing

Basic and Applied Science (I Lewkowich, Section Editor)

Exosomes in Allergic Airway Diseases

Neu im Fachgebiet HNO

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update HNO und bleiben Sie gut informiert – ganz bequem per eMail.